Background
Psychological Domains Measured
Measures visible sadness, emotional despair, facial expression changes, and outward depressive appearance.
Measures subjective feelings of sadness, hopelessness, emotional suffering, and depressed mood.
Measures anxiety, emotional tension, panic feelings, inner distress, and psychological discomfort.
Measures insomnia, disrupted sleep quality, reduced sleep duration, and nighttime difficulties.
Measures appetite loss, reduced desire for food, and eating difficulties associated with depression.
Measures focus problems, mental distraction, difficulty thinking clearly, and reduced cognitive concentration.
Measures fatigue, reduced motivation, slowed activity, and difficulty initiating everyday tasks.
Measures emotional numbness, reduced pleasure, emotional detachment, and inability to experience normal feelings.
Measures guilt, hopelessness, self-criticism, negative thinking, and pessimistic emotional beliefs.
Measures suicidal thinking, hopelessness about life, thoughts of death, and suicidal planning or preparation.
Procedure
This assessment is typically administered by a trained clinician, psychologist, psychiatrist, or qualified healthcare professional through a structured interview process.
Participants are rated according to the severity and intensity of depressive symptoms experienced during the previous week.
Each item is scored on a scale from 0 to 6, with higher scores indicating greater symptom severity and emotional impairment.
Participation
This assessment is intended for clinical, educational, and research purposes only.
Results should not be considered a standalone psychiatric diagnosis or substitute for professional psychological, psychiatric, or medical evaluation.
Individuals experiencing severe depressive symptoms, suicidal thoughts, emotional crisis, or major impairment in daily functioning are strongly encouraged to seek immediate support from a qualified mental health professional or emergency healthcare service.
Scoring & Interpretation
Responses are scored on a 0–6 severity scale according to symptom intensity and functional impact.
Higher scores generally indicate stronger depressive symptoms, emotional suffering, hopelessness, cognitive difficulties, and suicidal risk indicators.
The MADRS is especially recognized for its sensitivity to changes in depression severity and is commonly used to monitor treatment progress during psychiatric care.
Montgomery-Asberg Depression Rating Scale (MADRS) Questionnaire
Below is the Montgomery-Asberg Depression Rating Scale (MADRS), a digitally adapted 10- items self-assessment questionnaire. This assessment does not provide a clinical diagnosis, medical determination, or substitute for professional psychological evaluation.
Psychometric Norms
Current normative data for theCurrent normative data for the Montgomery-Asberg Depression Rating Scale (MADRS) are derived from 4 anonymous participant responses collected through TraitProfiler between 2026 and 2026. All response data are collected anonymously and are intended exclusively for educational, psychometric, and non-commercial research purposes.
Sources
- Montgomery, S. A., & Asberg, M. A new depression scale designed to be sensitive to change.